Guizhou Yibai Pharmaceutical Co. Ltd.SSE: 600594

(600594)"Guizhou Yibai Pharmaceutical Co., Ltd."Report for Q3 2026

· Issued by Guizhou Yibai Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600594 · · 12 pages · Chinese

Summary by 6ix AI

The report includes unaudited financial statements such as the consolidated balance sheet, income statement, and cash flow statement. It also highlights changes in major accounting data and financial indicators, along with non-recurring profit and loss items. The company assures the accuracy and completeness of the report's content, taking legal responsibility for any misrepresentation.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Guizhou Yibai Pharmaceutical Co. Ltd. on 6ix

Earlier from Guizhou Yibai Pharmaceutical

All Guizhou Yibai Pharmaceutical news releases